Curry-Jones syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1553OMIM:601707Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Curry-Jones syndrome (CJS) is an extremely rare multisystem disorder characterized by a distinctive combination of congenital anomalies including craniosynostosis (premature fusion of skull bones), agenesis of the corpus callosum (absence of the structure connecting the brain's hemispheres), polysyndactyly (extra and fused fingers or toes), and skin abnormalities. The condition was first described in 1987 and has been linked to postzygotic (somatic) mosaic mutations in the SMO gene, which encodes the Smoothened protein involved in the Hedgehog signaling pathway. Because the mutation arises after conception and is present in only some cells of the body, the condition occurs sporadically and is not inherited from parents. Key clinical features affect multiple body systems. Craniofacial abnormalities include craniosynostosis, colobomas of the eye (gaps in eye structures), and distinctive facial features. Neurological findings include corpus callosum abnormalities and intellectual disability of variable severity. Limb anomalies typically involve preaxial polysyndactyly, and characteristic skin findings include patchy areas of abnormal skin with an unusual texture, often described as having a distinctive pattern. Intestinal malformations and myxomas (benign soft tissue tumors) have also been reported. Some patients may develop medulloblastoma, a type of brain tumor, highlighting the importance of ongoing surveillance. There is no cure for Curry-Jones syndrome, and management is supportive and symptom-directed. Treatment typically involves a multidisciplinary team including neurosurgeons for craniosynostosis repair, ophthalmologists for eye abnormalities, orthopedic surgeons for limb anomalies, and neurologists for developmental monitoring. Tumor surveillance, particularly for medulloblastoma, is an important component of long-term care. Genetic counseling is recommended for affected families, though recurrence risk is very low given the somatic mosaic nature of the condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Optic disc colobomaHP:0000588Foot polydactylyHP:0001829Abnormality of thumb phalanxHP:0009602
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Curry-Jones syndrome.

View clinical trials →

No actively recruiting trials found for Curry-Jones syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Curry-Jones syndrome community →

No specialists are currently listed for Curry-Jones syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Curry-Jones syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Curry-Jones syndromeForum →

No community posts yet. Be the first to share your experience with Curry-Jones syndrome.

Start the conversation →

Latest news about Curry-Jones syndrome

No recent news articles for Curry-Jones syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Curry-Jones syndrome

What is Curry-Jones syndrome?

Curry-Jones syndrome (CJS) is an extremely rare multisystem disorder characterized by a distinctive combination of congenital anomalies including craniosynostosis (premature fusion of skull bones), agenesis of the corpus callosum (absence of the structure connecting the brain's hemispheres), polysyndactyly (extra and fused fingers or toes), and skin abnormalities. The condition was first described in 1987 and has been linked to postzygotic (somatic) mosaic mutations in the SMO gene, which encodes the Smoothened protein involved in the Hedgehog signaling pathway. Because the mutation arises aft

How is Curry-Jones syndrome inherited?

Curry-Jones syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Curry-Jones syndrome typically begin?

Typical onset of Curry-Jones syndrome is neonatal. Age of onset can vary across affected individuals.